Ibsrela (tenapanor) and Linzess (linaclotide) are commonly prescribed treatments for irritable bowel syndrome with ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

There are plenty of reasons you might wonder, “What pill is this?” WebMD’s Pill Identifier can help you put a name to an unknown medication. It identifies prescription and over-the-counter ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...

Eli Lilly's experimental oral pill, orforglipron, has shown promising results in Phase 3 trials, effectively lowering weight and blood sugar levels similar to Ozempic in diabetes patients.

Don’t recognize a tablet or capsule? Our Pill Identifier helps to find the name and image of an unknown prescription or over-the-counter medication. To start, enter details like pill imprint ...

Amitiza is available as the generic drug lubiprostone. A generic contains an exact copy of the active drug in a brand-name medication. A generic is considered just as safe and effective as the ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...

The jab averse can now rejoice! Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.